These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 11913736)

  • 41. Principles of hair cycle control.
    Paus R
    J Dermatol; 1998 Dec; 25(12):793-802. PubMed ID: 9990771
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging treatments in alopecia.
    Falto-Aizpurua L; Choudhary S; Tosti A
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):545-56. PubMed ID: 25330928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Telogen effluvium x female pattern hair loss: is there correlation?
    Brenner FM; Oldoni C
    An Bras Dermatol; 2019; 94(4):486-487. PubMed ID: 31644631
    [No Abstract]   [Full Text] [Related]  

  • 44. [Physiopathology and diagnosis of hair loss].
    Goos M
    Schweiz Med Wochenschr; 1971 Jun; 101(23):854-9. PubMed ID: 5578734
    [No Abstract]   [Full Text] [Related]  

  • 45. Telogen Effluvium - a review of the science and current obstacles.
    Chien Yin GO; Siong-See JL; Wang ECE
    J Dermatol Sci; 2021 Mar; 101(3):156-163. PubMed ID: 33541773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hair disorders in cancer survivors.
    Freites-Martinez A; Shapiro J; van den Hurk C; Goldfarb S; Jimenez JJ; Rossi AM; Paus R; Lacouture ME
    J Am Acad Dermatol; 2019 May; 80(5):1199-1213. PubMed ID: 29660423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. White hair in alopecia areata: Clinical forms and proposed physiopathologic mechanisms.
    Asz-Sigall D; Ortega-Springall MF; Smith-Pliego M; Rodríguez-Lobato E; Martinez-Velasco MA; Arenas R; Vincenzi C; Tosti A
    J Am Acad Dermatol; 2023 Oct; 89(4):758-763. PubMed ID: 30630022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical and intralesional therapies for alopecia areata.
    Alkhalifah A
    Dermatol Ther; 2011; 24(3):355-63. PubMed ID: 21689245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ULBP3: a marker for alopecia areata incognita.
    Moftah NH; El-Barbary RA; Rashed L; Said M
    Arch Dermatol Res; 2016 Aug; 308(6):415-21. PubMed ID: 27142445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hair biology and its comprehensive sequence in female pattern baldness: diagnosis and treatment modalities--Part I.
    Sehgal VN; Srivastava G; Aggarwal AK; Midha R
    Skinmed; 2013; 11(1):39-45; quiz 45. PubMed ID: 23540076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent modalities in treatment of telogen effluvium: Comparative study.
    Khattab FM; Rady A; Khashaba SA
    Dermatol Ther; 2022 Oct; 35(10):e15720. PubMed ID: 35851518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis: alopecia areata or not?
    Hoss DM; Grant-Kels JM
    Semin Cutan Med Surg; 1999 Mar; 18(1):84-90. PubMed ID: 10188847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of zinc in chronic telogen effluvium in serum and hair of patients with alopecia.
    Zufishan S; Haque Z; Nazar S; Afaq E; Aamir E; Rafique S
    J Pak Med Assoc; 2024 Feb; 74(1 (Supple-2)):S47-S50. PubMed ID: 38385471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ACTH on hair growth in alopecia areata and universalis.
    WILSON RA
    Lancet; 1952 Mar; 1(6709):646-7. PubMed ID: 14909509
    [No Abstract]   [Full Text] [Related]  

  • 55. Altered polyamine profiling in the hair of patients with androgenic alopecia and alopecia areata.
    Lee YR; Lew BL; Sim WY; Lee J; Hong J; Chung BC
    J Dermatol; 2019 Nov; 46(11):985-992. PubMed ID: 31464015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Methods of hair loss evaluation in patients with endocrine disorders].
    Olszewska M; Warszawik O; Rakowska A; Słowińska M; Rudnicka L
    Endokrynol Pol; 2011; 62 Suppl 1():29-34. PubMed ID: 22125108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alopecia Areata: a Comprehensive Review of Pathogenesis and Management.
    Trüeb RM; Dias MFRG
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):68-87. PubMed ID: 28717940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence-based approach to cutaneous hyperandrogenism in women.
    Schmidt TH; Shinkai K
    J Am Acad Dermatol; 2015 Oct; 73(4):672-90. PubMed ID: 26138647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis and management of alopecia in children.
    Castelo-Soccio L
    Pediatr Clin North Am; 2014 Apr; 61(2):427-42. PubMed ID: 24636654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Telogen effluvium: an etiopathogenetic theory.
    Rebora A
    Int J Dermatol; 1993 May; 32(5):339-40. PubMed ID: 8505158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.